Five things physicians and patients should question in hospice and palliative medicine

Daniel Fischberg, Janet Bull, David Casarett, Laura C. Hanson, Scott M. Klein, Joseph Rotella, Thomas Smith, C. Porter Storey, Joan Teno, Eric Widera

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Overuse or misuse of tests and treatments exposes patients to potential harm. The American Board of Internal Medicine Foundation's Choosing Wisely® campaign is a multiyear effort to encourage physician leadership in reducing harmful or inappropriate resource utilization. Via the campaign, medical societies are asked to identify five tests or procedures commonly used in their field, the routine use of which in specific clinical scenarios should be questioned by both physicians and patients based on the evidence that the test or procedure is ineffective or even harmful. The American Academy of Hospice and Palliative Medicine (AAHPM) was invited, and it agreed to participate in the campaign. The AAHPM Choosing Wisely Task Force, with input from the AAHPM membership, developed the following five recommendations: 1) Don't recommend percutaneous feeding tubes in patients with advanced dementia; instead, offer oral-assisted feeding; 2) Don't delay palliative care for a patient with serious illness who has physical, psychological, social, or spiritual distress because they are pursuing disease-directed treatment; 3) Don't leave an implantable cardioverter-defibrillator activated when it is inconsistent with the patient/family goals of care; 4) Don't recommend more than a single fraction of palliative radiation for an uncomplicated painful bone metastasis; and 5) Don't use topical lorazepam (Ativan®), diphenhydramine (Benadryl®), and haloperidol (Haldol®) (ABH) gel for nausea. These recommendations and their supporting rationale should be considered by physicians, patients, and their caregivers as they collaborate in choosing those treatments that do the most good and avoid the most harm for those living with serious illness.

Original languageEnglish (US)
Pages (from-to)595-605
Number of pages11
JournalJournal of Pain and Symptom Management
Volume45
Issue number3
DOIs
StatePublished - Mar 1 2013
Externally publishedYes

Fingerprint

Hospices
Physicians
Lorazepam
Diphenhydramine
Patient Care Planning
Implantable Defibrillators
Medical Societies
Enteral Nutrition
Haloperidol
Advisory Committees
Internal Medicine
Palliative Care
Nausea
Caregivers
Dementia
Palliative Medicine
Therapeutics
Gels
Radiation
Psychology

Keywords

  • ABH gel
  • artificial nutrition and hydration
  • bone metastasis
  • bone pain
  • Choosing Wisely®
  • dementia
  • heart failure
  • ICD
  • implantable cardioverter-defibrillator
  • lorazepam-haloperidol-diphenhydramine gel
  • nausea
  • palliative care
  • PEG
  • percutaneous endoscopic gastrostomy
  • quality of life
  • single-fraction radiation

ASJC Scopus subject areas

  • Nursing(all)
  • Clinical Neurology
  • Anesthesiology and Pain Medicine

Cite this

Fischberg, D., Bull, J., Casarett, D., Hanson, L. C., Klein, S. M., Rotella, J., ... Widera, E. (2013). Five things physicians and patients should question in hospice and palliative medicine. Journal of Pain and Symptom Management, 45(3), 595-605. https://doi.org/10.1016/j.jpainsymman.2012.12.002

Five things physicians and patients should question in hospice and palliative medicine. / Fischberg, Daniel; Bull, Janet; Casarett, David; Hanson, Laura C.; Klein, Scott M.; Rotella, Joseph; Smith, Thomas; Storey, C. Porter; Teno, Joan; Widera, Eric.

In: Journal of Pain and Symptom Management, Vol. 45, No. 3, 01.03.2013, p. 595-605.

Research output: Contribution to journalArticle

Fischberg, D, Bull, J, Casarett, D, Hanson, LC, Klein, SM, Rotella, J, Smith, T, Storey, CP, Teno, J & Widera, E 2013, 'Five things physicians and patients should question in hospice and palliative medicine', Journal of Pain and Symptom Management, vol. 45, no. 3, pp. 595-605. https://doi.org/10.1016/j.jpainsymman.2012.12.002
Fischberg, Daniel ; Bull, Janet ; Casarett, David ; Hanson, Laura C. ; Klein, Scott M. ; Rotella, Joseph ; Smith, Thomas ; Storey, C. Porter ; Teno, Joan ; Widera, Eric. / Five things physicians and patients should question in hospice and palliative medicine. In: Journal of Pain and Symptom Management. 2013 ; Vol. 45, No. 3. pp. 595-605.
@article{7062ae8795d44168a9520342bf5444f2,
title = "Five things physicians and patients should question in hospice and palliative medicine",
abstract = "Overuse or misuse of tests and treatments exposes patients to potential harm. The American Board of Internal Medicine Foundation's Choosing Wisely{\circledR} campaign is a multiyear effort to encourage physician leadership in reducing harmful or inappropriate resource utilization. Via the campaign, medical societies are asked to identify five tests or procedures commonly used in their field, the routine use of which in specific clinical scenarios should be questioned by both physicians and patients based on the evidence that the test or procedure is ineffective or even harmful. The American Academy of Hospice and Palliative Medicine (AAHPM) was invited, and it agreed to participate in the campaign. The AAHPM Choosing Wisely Task Force, with input from the AAHPM membership, developed the following five recommendations: 1) Don't recommend percutaneous feeding tubes in patients with advanced dementia; instead, offer oral-assisted feeding; 2) Don't delay palliative care for a patient with serious illness who has physical, psychological, social, or spiritual distress because they are pursuing disease-directed treatment; 3) Don't leave an implantable cardioverter-defibrillator activated when it is inconsistent with the patient/family goals of care; 4) Don't recommend more than a single fraction of palliative radiation for an uncomplicated painful bone metastasis; and 5) Don't use topical lorazepam (Ativan{\circledR}), diphenhydramine (Benadryl{\circledR}), and haloperidol (Haldol{\circledR}) (ABH) gel for nausea. These recommendations and their supporting rationale should be considered by physicians, patients, and their caregivers as they collaborate in choosing those treatments that do the most good and avoid the most harm for those living with serious illness.",
keywords = "ABH gel, artificial nutrition and hydration, bone metastasis, bone pain, Choosing Wisely{\circledR}, dementia, heart failure, ICD, implantable cardioverter-defibrillator, lorazepam-haloperidol-diphenhydramine gel, nausea, palliative care, PEG, percutaneous endoscopic gastrostomy, quality of life, single-fraction radiation",
author = "Daniel Fischberg and Janet Bull and David Casarett and Hanson, {Laura C.} and Klein, {Scott M.} and Joseph Rotella and Thomas Smith and Storey, {C. Porter} and Joan Teno and Eric Widera",
year = "2013",
month = "3",
day = "1",
doi = "10.1016/j.jpainsymman.2012.12.002",
language = "English (US)",
volume = "45",
pages = "595--605",
journal = "Journal of Pain and Symptom Management",
issn = "0885-3924",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Five things physicians and patients should question in hospice and palliative medicine

AU - Fischberg, Daniel

AU - Bull, Janet

AU - Casarett, David

AU - Hanson, Laura C.

AU - Klein, Scott M.

AU - Rotella, Joseph

AU - Smith, Thomas

AU - Storey, C. Porter

AU - Teno, Joan

AU - Widera, Eric

PY - 2013/3/1

Y1 - 2013/3/1

N2 - Overuse or misuse of tests and treatments exposes patients to potential harm. The American Board of Internal Medicine Foundation's Choosing Wisely® campaign is a multiyear effort to encourage physician leadership in reducing harmful or inappropriate resource utilization. Via the campaign, medical societies are asked to identify five tests or procedures commonly used in their field, the routine use of which in specific clinical scenarios should be questioned by both physicians and patients based on the evidence that the test or procedure is ineffective or even harmful. The American Academy of Hospice and Palliative Medicine (AAHPM) was invited, and it agreed to participate in the campaign. The AAHPM Choosing Wisely Task Force, with input from the AAHPM membership, developed the following five recommendations: 1) Don't recommend percutaneous feeding tubes in patients with advanced dementia; instead, offer oral-assisted feeding; 2) Don't delay palliative care for a patient with serious illness who has physical, psychological, social, or spiritual distress because they are pursuing disease-directed treatment; 3) Don't leave an implantable cardioverter-defibrillator activated when it is inconsistent with the patient/family goals of care; 4) Don't recommend more than a single fraction of palliative radiation for an uncomplicated painful bone metastasis; and 5) Don't use topical lorazepam (Ativan®), diphenhydramine (Benadryl®), and haloperidol (Haldol®) (ABH) gel for nausea. These recommendations and their supporting rationale should be considered by physicians, patients, and their caregivers as they collaborate in choosing those treatments that do the most good and avoid the most harm for those living with serious illness.

AB - Overuse or misuse of tests and treatments exposes patients to potential harm. The American Board of Internal Medicine Foundation's Choosing Wisely® campaign is a multiyear effort to encourage physician leadership in reducing harmful or inappropriate resource utilization. Via the campaign, medical societies are asked to identify five tests or procedures commonly used in their field, the routine use of which in specific clinical scenarios should be questioned by both physicians and patients based on the evidence that the test or procedure is ineffective or even harmful. The American Academy of Hospice and Palliative Medicine (AAHPM) was invited, and it agreed to participate in the campaign. The AAHPM Choosing Wisely Task Force, with input from the AAHPM membership, developed the following five recommendations: 1) Don't recommend percutaneous feeding tubes in patients with advanced dementia; instead, offer oral-assisted feeding; 2) Don't delay palliative care for a patient with serious illness who has physical, psychological, social, or spiritual distress because they are pursuing disease-directed treatment; 3) Don't leave an implantable cardioverter-defibrillator activated when it is inconsistent with the patient/family goals of care; 4) Don't recommend more than a single fraction of palliative radiation for an uncomplicated painful bone metastasis; and 5) Don't use topical lorazepam (Ativan®), diphenhydramine (Benadryl®), and haloperidol (Haldol®) (ABH) gel for nausea. These recommendations and their supporting rationale should be considered by physicians, patients, and their caregivers as they collaborate in choosing those treatments that do the most good and avoid the most harm for those living with serious illness.

KW - ABH gel

KW - artificial nutrition and hydration

KW - bone metastasis

KW - bone pain

KW - Choosing Wisely®

KW - dementia

KW - heart failure

KW - ICD

KW - implantable cardioverter-defibrillator

KW - lorazepam-haloperidol-diphenhydramine gel

KW - nausea

KW - palliative care

KW - PEG

KW - percutaneous endoscopic gastrostomy

KW - quality of life

KW - single-fraction radiation

UR - http://www.scopus.com/inward/record.url?scp=84875228234&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875228234&partnerID=8YFLogxK

U2 - 10.1016/j.jpainsymman.2012.12.002

DO - 10.1016/j.jpainsymman.2012.12.002

M3 - Article

C2 - 23434175

AN - SCOPUS:84875228234

VL - 45

SP - 595

EP - 605

JO - Journal of Pain and Symptom Management

JF - Journal of Pain and Symptom Management

SN - 0885-3924

IS - 3

ER -